Coeptis Therapeutics Statistics Share Statistics Coeptis Therapeutics has 3.51M
shares outstanding. The number of shares has increased by -91.21%
in one year.
Shares Outstanding 3.51M Shares Change (YoY) -91.21% Shares Change (QoQ) 8.39% Owned by Institutions (%) 0.01% Shares Floating 3.02M Failed to Deliver (FTD) Shares 4,246 FTD / Avg. Volume 10.63%
Short Selling Information The latest short interest is 55.57K, so 1.58% of the outstanding
shares have been sold short.
Short Interest 55.57K Short % of Shares Out 1.58% Short % of Float 1.87% Short Ratio (days to cover) 1.46
Valuation Ratios The PE ratio is -1.08 and the forward
PE ratio is -3.26.
Coeptis Therapeutics's PEG ratio is
0.
PE Ratio -1.08 Forward PE -3.26 PS Ratio 0 Forward PS n/a PB Ratio 3.32 P/FCF Ratio -1.59 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Coeptis Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.23,
with a Debt / Equity ratio of 0.44.
Current Ratio 0.23 Quick Ratio 0.23 Debt / Equity 0.44 Debt / EBITDA -0.14 Debt / FCF -0.21 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.96M Employee Count 5 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -1.06M Effective Tax Rate 9.78%
Stock Price Statistics The stock price has increased by 177% in the
last 52 weeks. The beta is -0.58, so Coeptis Therapeutics's
price volatility has been lower than the market average.
Beta -0.58 52-Week Price Change 177% 50-Day Moving Average 9.45 200-Day Moving Average 8.62 Relative Strength Index (RSI) 56.34 Average Volume (20 Days) 39,937
Income Statement
Revenue n/a Gross Profit -1.04M Operating Income -10.05M Net Income -9.81M EBITDA -10.05M EBIT -11.27M Earnings Per Share (EPS) -5.1
Full Income Statement Balance Sheet The company has 532.88K in cash and 1.4M in
debt, giving a net cash position of -866.17K.
Cash & Cash Equivalents 532.88K Total Debt 1.4M Net Cash -866.17K Retained Earnings -98.23M Total Assets 13.45M Working Capital -1M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -6.65M
and capital expenditures 0, giving a free cash flow of -6.65M.
Operating Cash Flow -6.65M Capital Expenditures n/a Free Cash Flow -6.65M FCF Per Share -3.45
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields COEP does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for COEP.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Dec 31, 2024. It was a
backward
split with a ratio of 1:20.
Last Split Date Dec 31, 2024 Split Type backward Split Ratio 1:20
Scores Altman Z-Score -9.42 Piotroski F-Score 3
